BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GREENWICH BIOSCIENCES, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Amendment

GREENWICH BIOSCIENCES, INC.

via GREENWICH BIOSCIENCES, INC.

4th Quarter (Oct 1 - Dec 31) · 2019Posted Jan 21, 2020Filing document ↗LDA record ↗

Expenses$250Kself-filed spend

Client

Name: GREENWICH BIOSCIENCES, INC.
Location: California · United States of America

Registrant

Firm: GREENWICH BIOSCIENCES, INC.
Description: Pharmaceuticals
Location: Sausalito, California, United States of America

Lobbying activities

1 issue

Banking
HR 1595 - Secure and Fair Enforcement Banking Act of 2019 or the SAFE Banking Act of 2019
LobbyistsDEBORAH LYNN WALTER
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.